These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5056625)

  • 21. Inhibition of normal plasma lipases by serum from chronic renal failure patients.
    Crawford GA; Savdie E; Stewart JH; Mahony JF
    Trans Am Soc Artif Intern Organs; 1979; 25():426-30. PubMed ID: 524618
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolism of red blood cells in chronic renal failure. I. Glycolytic enzyme levels.
    Rodríguez-Commes JL; Tabernero JM; Martin-Vasallo P; De Castro S; Battaner E
    Nephron; 1979; 24(1):21-4. PubMed ID: 226898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nature of the inhibitors of lactate dehydrogenase in uremic dialysates.
    Wilkinson JH; Fujimoto Y; Senesky D; Ludwig GD
    J Lab Clin Med; 1970 Jan; 75(1):109-19. PubMed ID: 4378401
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on erythrocyte metabolism in chronic kidney diseases].
    Buscarini L
    Folia Haematol (Frankf); 1964; 9(3):384-9. PubMed ID: 4171021
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum haptoglobin and lactic dehydrogenase during haemodialysis.
    Toshner D; Krasner N; Macdougall AI
    Nephron; 1972; 9(4):235-41. PubMed ID: 4645710
    [No Abstract]   [Full Text] [Related]  

  • 26. Erythrocyte glutathione transferase activity: a possible early biomarker for blood toxicity in uremic diabetic patients.
    Noce A; Fabrini R; Dessì M; Bocedi A; Santini S; Rovella V; Pastore A; Tesauro M; Bernardini S; Di Daniele N; Ricci G
    Acta Diabetol; 2014 Apr; 51(2):219-24. PubMed ID: 23818012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuraminidase-like activity in sera of uremic anemic patients.
    Levinsky H; Gafter U; Levi J; Allalouf D
    Nephron; 1984; 37(1):35-8. PubMed ID: 6717703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G-6-PD activity of the red cells in chronic renal failure.
    Mellissinos KG; Vlassopoulos KS; Drivas GJ; Tsoukandas AG
    Nephron; 1977; 18(3):156-61. PubMed ID: 870844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Behavior of aspartate and alanine aminotransferases (AspAT, A1AT), lactate dehydrogenase (LDH), alpha-hydroxybutyrate dehydrogenase (HBDH), Sorbitol dehydrogenase (SDH) and aldolase during hemodialysis].
    Zazgornik J; Schmidt P; Kopsa H
    Wien Klin Wochenschr; 1973 Jan; 85(3):35-6. PubMed ID: 4683446
    [No Abstract]   [Full Text] [Related]  

  • 30. Adherence of uremic erythrocytes to vascular endothelium decreases endothelial nitric oxide synthase expression.
    Bonomini M; Pandolfi A; Di Pietro N; Sirolli V; Giardinelli A; Consoli A; Amoroso L; Gizzi F; De Lutiis MA; Felaco M
    Kidney Int; 2005 May; 67(5):1899-906. PubMed ID: 15840037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic studies on red cells from patients with chronic renal disease on haemodialysis.
    Wallas CH
    Br J Haematol; 1974 Jan; 26(1):71-8. PubMed ID: 4853177
    [No Abstract]   [Full Text] [Related]  

  • 32. Alkaline phosphatase activity in leukocytes of patients with renal failure treated with dialyses.
    Kuska J
    Pol Med J; 1971; 10(3):570-6. PubMed ID: 5124125
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of the inhibitor of glucose utilization, isolated from serum of patients in uremia, upon morphology and membrane permeability of erythrocytes (author's transl)].
    Gajdos M; Dzúrik R
    Bratisl Lek Listy; 1974; 62(1):29-34. PubMed ID: 4848602
    [No Abstract]   [Full Text] [Related]  

  • 34. A response to "Serum-ethanol determination: comparison of lactate and lactate dehydrogenase interference in three enzymatic assays".
    Winek CL; Wahba WW
    J Anal Toxicol; 1996; 20(3):211-2. PubMed ID: 8735208
    [No Abstract]   [Full Text] [Related]  

  • 35. Alterations in serum enzymes in chronic renal failure.
    Bailey GL; Katz AI; Hampers CL; Merrill JP
    JAMA; 1970 Sep; 213(13):2263-5. PubMed ID: 5468935
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of erythrocyte uroporphyrinogen I synthetase activity in chronic renal failure.
    Andriolo A; Mocelin AJ; Stella SR; Ajzen H; Ramos OL
    Clin Chim Acta; 1980 Jun; 104(2):241-4. PubMed ID: 7389135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamylated plasma protein in renal failure.
    Oimomi M; Nishimoto S; Matsumoto S; Hatanaka H; Ishikawa K; Kawasaki T; Yoshimura Y; Baba S
    Nihon Jinzo Gakkai Shi; 1986 Mar; 28(3):269-71. PubMed ID: 3723861
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure.
    Mimic-Oka J; Simic T; Ekmescic V; Dragicevic P
    Clin Nephrol; 1995 Jul; 44(1):44-8. PubMed ID: 7554532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monoamine oxidase activity in patients with chronic renal failure and in experimental uremia in rats].
    Ksiazek A
    Pol Arch Med Wewn; 1978 Aug; 60(2):147-51. PubMed ID: 714710
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies of the correlation between the glycolytic enzymes and general red-cell parameters in the erythrocytes in chronic renal failure (author's transl)].
    Rodríguez Commes JL; Martín Vasallo P; Tabernero JM; Alonso Lancho MT; de Castro S; Battaner E
    Sangre (Barc); 1980; 25(5):541-8. PubMed ID: 7466540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.